What will be the economic consequences of coronavirus on fundraising in digital health, MedTech and biotech?
About this Event
Investments in digital health and biotech have been steadily rising in the last few years. When the coronavirus reached Europe and the US, the use of telemedicine surged, and numerous companies built digital solutions within days to support healthcare and individuals. What will be the economic consequences of coronavirus on fundraising?
Join us for the webinar on 9 April at 2 pm, where we will talk about the funding trends before the pandemic and discuss expectations of the future.
Please fill out
this survey before the event and share your thoughts, questions, which we will then address together:!
Agenda:
14:00-14:05 Introduction
14:05 – 14:20
Overview of the global digital health scene up until now, COVID-19 related investments (Levi Shapiro, mHealth Israel)
14:20-14:35
Rethinking financial landscape in healthcare and future trends given the COVID-19 induced economic crisis (Nana Bit-Avragim, digital health business architect)
14:35-15:10
Round table: Effects of COVID-19 on business ( Nana Bit-Avragim, Levi Shapiro, Giovanni Loser, Blaž Triglav)
15:10-15:20
Q&A with the audience
The webinar will be moderated by Tjaša Zajc (Faces of digital health).
Speakers:
Nana Bit-Avragim, digital health business architect
Nana Bit-Avragim is a physician-scientist and digital health business architect with a focus on radical innovation. In the past, she had successfully developed and executed a broad scope of networking platforms and innovation programs between NGOs, SMEs and academia at Charité Foundation; German hub of Singularity University, an executive education organisation based on NASA Research Park in Silicon Valley; and lately at Brandenburg Medical School. Actively transforming the current healthcare industry, Nana enjoys serving as an advisor to several digital health companies in the UK, Germany, Switzerland and Israel.
Linkedin,
Twitter
Levi Shapiro, Founder of mHealth Israel
Levi Shapiro is a global thought-leader in the field of digital health and Health technology. He runs the digital health program in the BioMED MBA at Hebrew University, where his course is available for e-learning. Mr. Shapiro is the Founder of mHealth Israel, a non-profit supporting Israel’s healthtech, Health IT and MedTech startup community, with more than 7,000 members. He holds several Board positions and is a retained advisor by prominent global healthcare organizations. Over a career spanning more than two decades, including seven years in Beijing and Tokyo, Mr. Shapiro launched new business units (IBM), new products and services (Toyota) and a variety of technology startups. He is an investor and Board Member in numerous Israeli HealthTech startups and formerly a General Partner in the Veritas Digital Health fund. Mr. Shapiro holds degrees from Tulane (BA), Cornell (Asian Studies, FALCON program) and MIT (MBA).
Linkedin,
Twitter
Giovanni Loser, CEO of BioValley Investments Partner S.r.l.
Giovanni Loser is a versatile professional with a cross-industry career history steering global operations on behalf of start-up and established organizations. His career portfolio is comprised of entities as illycaffe, Fortress Investment group, Aedes, Rinascente and Pirelli Group. His areas of expertise include finance, strategy development and execution, digital transformation, program/project management, and contract negotiation in finance, retail, consumer goods, digital, high technology and life science.
Linkedin
Blaž Triglav, CEO of Mediately
Blaž Triglav is an experienced executive in the digital healthcare space, helping doctors make better decisions with digital tools and helping pharmaceutical companies market effectively in the digital age. He co-founded Mediately in 2013 and launched Mediately Drugs app, which strives to become the Nr.1 digital medical tool in Central and Eastern Europe used by more than 100,000 doctors.
Linkedin,
Twitter